Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Submitted by
admin
on July 9, 2017 - 11:33am
Source:
Endpoints
News Tags:
Zealand Pharma
IPO
NASDAQ
dasiglucagon
hypoglycemia
glepaglutide
short bowel syndrome
Headline:
Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Do Not Allow Advertisers to Use My Personal information
